Trachte G J, Lefer A M
Arch Int Pharmacodyn Ther. 1978 Apr;232(2):309-20.
Anesthetized cats were hemorrhaged to a mean arterial blood pressure of 40 mm Hg for 120 minutes. Cats given dexamethasone (6 mg/kg, i.v.) at the time of hemorrhage and again (3 mg/kg, i.v.) at the time of reinfusion maintained post-reinfusion arterial blood pressure at a higher level than cats given the steroid vehicle. In addition, dexamethasone treated cats exhibited higher post-reinfusion liver blood flows than vehicle treated hemorrhaged cats. Dexamethasone significantly retarded the rise in plasma cathepsin D and amino-nitrogen activities during hemorrhage, and prevented the accumulation of a myocardial depressant factor (MDF) in the circulating blood. Dexamethasone had no significant effect on isolated cat papillary muscle or aortic strips. It appears that dexamethasone exerts its beneficial effect in hemorrhage shock primarily by stabilizing lysosomal membranes and the subsequent prevention of proteolysis and MDF formation rather than by a direct vasodilator or inotropic effect.
将麻醉后的猫放血,使其平均动脉血压降至40毫米汞柱,并持续120分钟。在放血时给予地塞米松(6毫克/千克,静脉注射),并在再灌注时再次给予(3毫克/千克,静脉注射),与给予类固醇溶媒的猫相比,这些猫在再灌注后的动脉血压维持在更高水平。此外,接受地塞米松治疗的猫在再灌注后的肝血流量高于接受溶媒治疗的放血猫。地塞米松显著延缓了放血期间血浆组织蛋白酶D和氨基氮活性的升高,并防止了循环血液中心肌抑制因子(MDF)的积累。地塞米松对离体猫乳头肌或主动脉条没有显著影响。地塞米松在出血性休克中发挥有益作用,似乎主要是通过稳定溶酶体膜以及随后防止蛋白水解和MDF形成,而不是通过直接的血管舒张或变力作用。